| Financial Year |
March 31 2023 |
| Monetary Funds |
215,192,685.44 |
| Held-for-trading Financial Assets |
35,000,000.00 |
| Notes Receivable |
162,798,928.17 |
| Accounts Receivable |
882,712,322.25 |
| Advances to Suppliers |
55,422,302.17 |
| Other Receivables |
14,543,231.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
575,485,477.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,422,891.33 |
| Total Current Assets |
2,036,354,770.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
148,042,751.20 |
| Long-term Equity Investment |
5,357,534.59 |
| Investment Properties |
-- |
| Fixed Assetes |
159,802,462.90 |
| Under-construction Projects |
4,033,722.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
192,499,688.60 |
| R&D expenses |
30,490,985.92 |
| Goodwill |
7,315,737.86 |
| Long-Term Deferred and Prepaid Expenses |
4,173,513.34 |
| Deferred Income Tax Assets |
45,240,377.72 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
617,205,411.25 |
| Total Assets |
2,653,560,182.08 |
| Short-Term Loans |
250,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,703,217.43 |
| Accounts Payable |
341,254,005.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
39,919,104.98 |
| Taxes Payable |
34,833,387.48 |
| Interest Payable |
269,386.98 |
| Dividend Payable |
-- |
| Other payables |
2,542,573.43 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,169,072.90 |
| Other Current Liabilities |
2,484,676.80 |
| Sub-Total of Current Liabilities |
715,439,174.99 |
| Long-term Loans |
30,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
11,343,042.76 |
| Deferred Income Tax Liabilities |
2,306,688.34 |
| Other Non-Current Liabilities |
6,366,747.36 |
| Sub-Total of Non-Current Liabilities |
75,776,108.23 |
| Total Liabilities |
791,215,283.22 |
| Paid-In Capital(Or Share Stock) |
564,546,000.00 |
| Capital Surplus |
278,831,572.74 |
| Surplus Reserve |
70,774,489.54 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
758,436,865.17 |
| Minority Stockholder's Interest |
184,134,966.83 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,678,209,932.03 |
| Owner's Equity（Stockholder's Equity） |
1,862,344,898.86 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,653,560,182.08 |
